Robuta

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2019.24.8.1800068?ref=foodsafetynews.com Eurosurveillance | Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing... Introduction Haemolytic uraemic syndrome (HUS) related to Shiga toxin-producing Escherichia coli (STEC) is the leading cause of acute renal failure in young... haemolytic uraemic syndrome shiga toxin eurosurveillance paediatric related https://www.nice.org.uk/guidance/ta710 Overview | Ravulizumab for treating atypical haemolytic uraemic syndrome | Guidance | NICE Evidence-based recommendations on ravulizumab (Ultomiris) for treating atypical haemolytic uraemic syndrome in people weighing 10 kg or more haemolytic uraemic syndrome overview ravulizumab treating atypical https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2017.22.21.30541 Eurosurveillance | Ongoing haemolytic uraemic syndrome (HUS) outbreak caused by sorbitol-fermenting... We report an ongoing, protracted and geographically dispersed outbreak of haemolytic uraemic syndrome (HUS) and gastroenteritis in Germany, involving 30 cases... haemolytic uraemic syndrome eurosurveillance ongoing https://www.servicesaustralia.gov.au/atypical-haemolytic-uraemic-syndrome?context=20 Atypical haemolytic uraemic syndrome - Health professionals - Services Australia The PBS subsidises eculizumab and ravulizumab for patients with atypical haemolytic uraemic syndrome (aHUS). haemolytic uraemic syndrome health professionals atypical services australia